MYCN and neuroblastoma: While DFMO treatment significantly inhibited the proliferation in both MYCN2 (−) and MYCN2 (+) compared to untreated cells (Fig. 2B), the inhibitory effect of DFMO was significantly enhanced when MYCN was overexpressed in NB cells.